ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Inhibitory FcγRIIB Functionally Inhibits Donor-Reactive CD8+ Memory T Cell Responses Following Transplantation.

D. Pinelli, M. Wagener, D. Liu, I. Badell, M. Ford.

Emory Transplant Center, Emory University, Atlanta, GA.

Meeting: 2016 American Transplant Congress

Abstract number: 348

Keywords: Co-stimulation, Graft survival, Immunoglobulins (Ig), T cells

Session Information

Date: Monday, June 13, 2016

Session Name: Concurrent Session: Pathways of Allograft Rejection: Animal Models

Session Time: 4:30pm-6:00pm

 Presentation Time: 4:54pm-5:06pm

Location: Room 310

Related Abstracts
  • 2B4 Induced by Selective CD28 Blockade Functionally Regulates Alloreactive Memory CD8+ T Cell Responses
  • ESAT-6 Inhibits Donor-Specific Memory CD8+ T Cell Generation and Alloimmune Responses.

Fc receptors are expressed by many types of immune cells and bind to the constant portion of immunoglobulin to mediate their effector functions. The inhibitory receptor FcγRIIB is an important negative regulator of humoral and cellular immune responses. Previous studies by our group revealed that FcγRIIB-/- (KO) mice are resistant to the ability of CTLA4-Ig to prolong graft survival in a minor mismatch (OVA) model of skin transplantation. Here, we investigate the mechanisms underlying this resistance. Interestingly, enhanced humoral responses in KO mice were not responsible for the CTLA4-Ig-resistant rejection, as we observed that CTLA4-Ig treatment was able to inhibit graft-specific antibody formation in both WT and KO mice, indicating that a different mechanism may be responsible for the accelerated rejection seen in KO animals.

Given the interplay between T and B cells during alloreactive responses and the rise in the use of monoclonal antibody therapy to control T cell alloreactivity, we sought to investigate the role that FcγRIIB may play in T cell-mediated graft rejection. While T cells have long been thought to not express Fc receptors, we observed the expression of FcγRIIB on allospecific CD4 and CD8 effector T cells by day 14 following skin transplantation (61.5% and 64.4%, respectively), and this expression was maintained at a high level on memory T cells. Furthermore, we showed that most allospecific cells capable of making TNF and IFNγ in response to ex vivo restimulation also coexpressed FcγRIIB (88.3%).

With this novel finding of high FcγRIIB expression on donor-reactive memory T cells and the fact that memory T cells are a significant barrier to transplantation, we sought to determine if FcγRIIB functionally impacts recall responses to a graft. We transferred OVA-specific CD4 and CD8 T cells to B6 mice and allowed them to fully reject mOVA skin grafts. At a memory timepoint, these mice were given a second mOVA graft, and recipients were either left untreated or treated with the FcγRIIB-blocking 2.4G2 antibody. We observed a greater expansion of CD8 T cells in the draining lymph node of 2.4G2-treated animals, suggesting that FcγRIIB plays a significant functional role in the control of secondary donor-reactive CD8 T cell expansion in this model. Taken together, these data identify FcγRIIB as a novel coinhibitory pathway regulating donor-reactive memory CD8 T cell responses in the setting of transplantation.

CITATION INFORMATION: Pinelli D, Wagener M, Liu D, Badell I, Ford M. Inhibitory FcγRIIB Functionally Inhibits Donor-Reactive CD8+ Memory T Cell Responses Following Transplantation. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Pinelli D, Wagener M, Liu D, Badell I, Ford M. Inhibitory FcγRIIB Functionally Inhibits Donor-Reactive CD8+ Memory T Cell Responses Following Transplantation. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/inhibitory-fcriib-functionally-inhibits-donor-reactive-cd8-memory-t-cell-responses-following-transplantation/. Accessed January 27, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.

    Visit Our Partner Sites

    American Transplant Congress (ATC)

    Visit the official site for the American Transplant Congress »

    American Journal of Transplantation

    The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

    American Society of Transplantation (AST)

    An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

    American Society of Transplant Surgeons (ASTS)

    The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

    Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

    Privacy Policy

    loading Cancel
    Post was not sent - check your email addresses!
    Email check failed, please try again
    Sorry, your blog cannot share posts by email.
    This site uses cookies: Find out more.